Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Allogeneic, Hematopoietic Cell Transplant (HCT)”

111 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 111 results

Early research (Phase 1)Looking for participantsNCT07104799
What this trial is testing

Momelotinib During and After HCT in Myelofibrosis

Who this might be right for
MyelofibrosisHematopoietic Cell Transplantation (HCT)
Massachusetts General Hospital 28
Not applicableUnknownNCT04724642
What this trial is testing

COVID-19 Vaccine in Patients After Allogeneic HCT, CAR-T Therapy and With Primary Immune Deficiency

Who this might be right for
Allogenic Hematopoietic Cell TransplantCAR-T TherapyPrimary Immunodeficiency
Tel-Aviv Sourasky Medical Center 110
Not applicableStudy completedNCT03200977
What this trial is testing

Safety of Allogeneic Hematopoietic Cell Transplantation (HCT) For Patients With Classical Hodgkin Lymphoma (CHL) Treated With Nivolumab

Who this might be right for
Lymphoma
Bristol-Myers Squibb 95
Not applicableStudy completedNCT03609814
What this trial is testing

Study of Clofarabine and Fludarabine Drug Exposure in Pediatric Bone Marrow Transplantation (HCT)

Who this might be right for
Hematologic MalignanciesNonmalignant DiseasesImmunodeficiencies+5 more
University of California, San Francisco 30
Early research (Phase 1)Looking for participantsNCT05088356
What this trial is testing

Reduced Intensity Allogeneic HCT in Advanced Hematologic Malignancies w/T-Cell Depleted Graft

Who this might be right for
Allogeneic Hematopoietic Cell Transplantation (HCT)Advanced Hematologic MalignanciesAcute Leukemia+3 more
Stanford University 60
Testing effectiveness (Phase 2)Study completedNCT03613727
What this trial is testing

Therapeutic Use of Intravenous Vitamin C in Allogeneic Stem Cell Transplant Recipients

Who this might be right for
Lymphoid LeukemiaMyeloid LeukemiaMonocytic Leukemia+1 more
Virginia Commonwealth University 61
Testing effectiveness (Phase 2)Study completedNCT00577278
What this trial is testing

A Phase II Study of Allo-HCT for B-Cell NHL Using Zevalin, Fludarabine and Melphalan

Who this might be right for
Graft Versus Host DiseaseLeukemiaLymphoma
City of Hope Medical Center 41
Early research (Phase 1)Study completedNCT04139577
What this trial is testing

FMT In High-Risk Acute GVHD After ALLO HCT

Who this might be right for
Acute Graft-Versus-Host Disease (Gvhd) GradeHematopoietic Cell TransplantationFecal Microbiota Transplant
Massachusetts General Hospital 10
Early research (Phase 1)UnknownNCT06164288
What this trial is testing

Safety and Efficacy Study of hAESCs Therapy for aGVHD

Who this might be right for
GVHD,Acute
Shanghai iCELL Biotechnology Co., Ltd, Shanghai, China 18
Testing effectiveness (Phase 2)Study completedNCT00847639
What this trial is testing

Safety Study of Lenalidomide Maintenance Therapy Post Allogeneic HCT for High-risk Multiple Myeloma

Who this might be right for
Multiple Myeloma
Center for International Blood and Marrow Transplant Research 30
Testing effectiveness (Phase 2)Looking for participantsNCT05736419
What this trial is testing

Immune Suppression Treatment for People With Sickle Cell Disease or β-Thalassemia Who Are Going to Receive an Allogeneic Hematopoietic Cell Transplantation (HCT)

Who this might be right for
Sickle Cell DiseaseThalassemia, BetaThalassemia
Memorial Sloan Kettering Cancer Center 24
Not applicableUnknownNCT03337568
What this trial is testing

Allogeneic HCT Using Uniform Conditioning Regimen Regardless of Donors (MS, MU, or HF) for AML in Remission

Who this might be right for
Acute Myeloid Leukemia
Asan Medical Center 110
Not applicableStudy completedNCT02077218
What this trial is testing

Computed Tomography and Biomarker Analysis in Diagnosing Coronary Artery Disease in Asymptomatic Patients Who Have Undergone Stem Cell Transplant

Who this might be right for
Cancer SurvivorDiabetes MellitusHypertension
City of Hope Medical Center 20
Early research (Phase 1)Ended earlyNCT04239989
What this trial is testing

Itacitinib for the Treatment of Bronchiolitis Obliterans Syndrome After Donor Hematopoietic Cell Transplant

Who this might be right for
Bronchiolitis Obliterans
M.D. Anderson Cancer Center 8
Testing effectiveness (Phase 2)Looking for participantsNCT07359859
What this trial is testing

Ruxolitinib for Preventing Graft-Versus-Host Disease in People With a Hematologic Malignancy Who Will Receive a Stem Cell Transplant

Who this might be right for
Hematologic Malignancies
Memorial Sloan Kettering Cancer Center 40
Testing effectiveness (Phase 2)Study completedNCT01809847
What this trial is testing

Ofatumumab Induction and Maintenance in Elderly Patients With Poor Risk CLL in the Context of Allogeneic Transplantation

Who this might be right for
Chronic Lymphatic Leukemia
Technische Universität Dresden 20
Early research (Phase 1)Study completedNCT02917096
What this trial is testing

Ruxolitinib Phosphate and Chemotherapy Given Before and After Reduced Intensity Donor Stem Cell Transplant in Treating Patients With Myelofibrosis

Who this might be right for
Primary MyelofibrosisSecondary Myelofibrosis
City of Hope Medical Center 18
Early research (Phase 1)Not Yet RecruitingNCT07302776
What this trial is testing

TACrolimus Targeted Immunosuppression Cessation in ALlogeneic HCT

Who this might be right for
GVHDHematopoietic Cell Transplantation (HCT)Acute Myeloid Leukemia (AML)+4 more
Stanford University 50
Testing effectiveness (Phase 2)Ended earlyNCT05984199
What this trial is testing

Donor-Derived Anti-CD33 CAR T Cell Therapy (VCAR33) in Patients With Relapsed or Refractory AML After Allogeneic Hematopoietic Cell Transplant

Who this might be right for
Leukemia, Myeloid, Acute
Vor Biopharma 38
Not applicableLooking for participantsNCT05335434
What this trial is testing

Intraoral Photobiomodulation Therapy to Prevent Oral Mucositis in Patients Undergoing Hematopoietic Cell Transplantation

Who this might be right for
Myeloablative Allogeneic Hematopoietic Cell TransplantationIntraoral Photobiomodulation TherapyOral Mucositis+1 more
Dana-Farber Cancer Institute 20
Load More Results